- Home
- VRME vs IMRN Comparison
VRME vs IMRN Comparison
Compare VRME & IMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRME
- IMRN
- Stock Information
- Founded
- VRME 1999
- IMRN 1994
- Country
- VRME United States
- IMRN Australia
- Employees
- VRME N/A
- IMRN N/A
- Industry
- VRME EDP Services
- IMRN Biotechnology: Pharmaceutical Preparations
- Sector
- VRME Technology
- IMRN Health Care
- Exchange
- VRME Nasdaq
- IMRN Nasdaq
- Market Cap
- VRME 14.5M
- IMRN 15.0M
- IPO Year
- VRME N/A
- IMRN N/A
- Fundamental
- Price
- VRME $1.35
- IMRN $2.25
- Analyst Decision
- VRME Buy
- IMRN Strong Buy
- Analyst Count
- VRME 1
- IMRN 1
- Target Price
- VRME $1.50
- IMRN $5.00
- AVG Volume (30 Days)
- VRME 14.8K
- IMRN 7.0K
- Earning Date
- VRME 11-06-2024
- IMRN 10-22-2024
- Dividend Yield
- VRME N/A
- IMRN N/A
- EPS Growth
- VRME N/A
- IMRN N/A
- EPS
- VRME N/A
- IMRN N/A
- Revenue
- VRME $25,428,000.00
- IMRN $3,271,194.00
- Revenue This Year
- VRME $1.14
- IMRN N/A
- Revenue Next Year
- VRME $10.56
- IMRN N/A
- P/E Ratio
- VRME N/A
- IMRN N/A
- Revenue Growth
- VRME N/A
- IMRN 171.67
- 52 Week Low
- VRME $0.85
- IMRN $1.48
- 52 Week High
- VRME $2.45
- IMRN $5.96
- Technical
- Relative Strength Index (RSI)
- VRME 51.51
- IMRN 32.37
- Support Level
- VRME $1.31
- IMRN $2.66
- Resistance Level
- VRME $1.43
- IMRN $2.73
- Average True Range (ATR)
- VRME 0.10
- IMRN 0.19
- MACD
- VRME -0.01
- IMRN -0.06
- Stochastic Oscillator
- VRME 44.00
- IMRN 24.04
About VRME VerifyMe Inc.
VerifyMe Inc together with its subsidiaries, is a traceability and customer support services provider using specialized software and process technology. The company operates a Precision Logistics Segment and an Authentication Segment to provide specialized logistics for time-and-temperature sensitive products, as well as item-level traceability, anti-diversion and anti-counterfeit protection, brand protection and enhancement technology solutions. It Generates the majority of its revenue from the Precision Logistics Segment. Through its Precision Logistics segment, it provides a value-added service for sensitive parcel management driven by a proprietary software platform that provides predictive analytics from key metrics such as pre-shipment weather analysis, flight-tracking, and Others.
About IMRN Immuron Limited
Immuron Ltd is a clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.